Trial Profile
Silipide (Siliphos) in early breast cancer
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Sep 2015
Price :
$35
*
At a glance
- Drugs Silibinin (Primary)
- Indications Breast cancer
- Focus Pharmacodynamics
- 01 Sep 2015 New trial record